A Study to Test How Well Different Doses of BI 3822971 Are Tolerated by People With Advanced Cancer (Solid Tumours)
Clinical trial NCT07744152 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07744152
- Sponsor
- Boehringer Ingelheim
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-31
- Primary completion
- 2030-01-15
- Enrollment
- 137
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.